-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $9

Benzinga·11/14/2025 13:00:34
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $8.5 to $9.